Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.
Retinoic acid is a promising tool in adjuvant cancer therapies, including refractory thyroid cancer, and its biological role is mediated by the retinoic acid receptor beta (RARβ). However, expression of RARβ is lowered in papillary thyroid carcinoma (PTC), contributing to promotion of tumor growth a...
Main Authors: | Agnieszka Anna Czajka, Anna Wójcicka, Anna Kubiak, Marta Kotlarek, Elwira Bakuła-Zalewska, Łukasz Koperski, Wiesław Wiechno, Krystian Jażdżewski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4807079?pdf=render |
Similar Items
-
The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma
by: Marta Kotlarek, et al.
Published: (2018-02-01) -
The Oncogenic Pathway of microRNA-146b in Human Papillary Thyroid Carcinoma
by: Chen Kai Chou, et al.
Published: (2016) -
MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer
by: Chen-Kai Chou, et al.
Published: (2017-03-01) -
Association of Cigarette Smoking with Aberrant Methylation of the Tumor Suppressor Gene RARβ2 in Papillary Thyroid Cancer
by: Katja eKiseljak-Vassiliades, et al.
Published: (2011-12-01) -
MiR-181a-5p Regulates NIS Expression in Papillary Thyroid Carcinoma
by: Wojciech Gierlikowski, et al.
Published: (2021-06-01)